My Diabetes and Me: Study protocol for a randomised controlled trial to test the clinical and cost-effectiveness of a diabetes self-management education programme for adults with intellectual disabilities

  • Laurence Taggart*
  • , Gary McDermott*
  • , Alison Dunkley
  • , Maria Truesdale
  • , Vivien Coates
  • , Kamlesh Khunti
  • , Mike Clarke
  • , Dan Pollard
  • , Alan Brennan
  • , Michelle Hadjiconstantinou
  • , Molly Caba
  • , Colette Jackson
  • , Aimee Anderson Smyth
  • , Cliona McDowell
  • , Ashley Agus
  • , Sorcha Toase
  • , Janet Schofield
  • , Rosie Kelly
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Background
International guidelines recommend structured diabetes education to empower individuals with type 2 diabetes (T2D). While DESMOND is an effective programme for T2D management, it is often inaccessible to people with intellectual disabilities (ID) due to their unique needs. There is limited evidence on the effectiveness of adapted T2D education for this group, despite the importance of tailored support in preventing complications and early mortality. We previously adapted the DESMOND programme for adults with ID, creating DESMOND-ID. A feasibility study showed it is possible to recruit and deliver the programme to adults with ID and their carers, who found it valuable. Initial findings suggest DESMOND-ID may improve blood glucose control, warranting further investigation through a large-scale randomised controlled trial (RCT).

Methods
The "My Diabetes & Me" study will be conducted in two stages: an internal pilot and a main RCT. The pilot will recruit 108 participants over 10 months to assess recruitment and retention, using glycated haemoglobin (HbA1c, mmol/mol) at six months as the primary outcome. This will inform the design of the main study. Across both stages, 450 participants will be randomly assigned to receive either the DESMOND-ID intervention or treatment as usual (TAU). The intervention group, with their carers, will attend weekly sessions for seven weeks, plus two booster sessions at one and three months post-programme. Primary outcome is HbA1c at six months. Secondary outcomes include HbA1c at 12 and 18 months (pilot only), anthropometric data, self-reported outcomes, and other risk factors. A process evaluation will explore barriers and facilitators to implementation using qualitative and quantitative methods.

Conclusion
DESMOND-ID is the first structured T2D education programme tailored for adults with ID, and this RCT is the first to evaluate its clinical and cost-effectiveness.
Original languageEnglish
Article number93
Number of pages19
JournalNIHR Open Research
Volume5
DOIs
Publication statusPublished - 06 Oct 2025

Keywords

  • Type 2 diabetes
  • Hba1c
  • Self-management
  • Education Programme
  • Randomised Controlled Trial.
  • Keywords: Intellectual Disability

Fingerprint

Dive into the research topics of 'My Diabetes and Me: Study protocol for a randomised controlled trial to test the clinical and cost-effectiveness of a diabetes self-management education programme for adults with intellectual disabilities'. Together they form a unique fingerprint.

Cite this